CONNECT WITH US
HealthTech

HealthTech

People with diabetes demand greater control over health data in new digital rights charter

Medical Xpress logo

Published on

Add as a preferred source on Google
People with diabetes demand greater control over health data in new digital rights charter

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

A new international Diabetes Data Rights Charter is calling for people with diabetes to have far greater control over the health data generated by 24/7 diabetes monitoring devices.

Developed through an 18-month international collaboration involving those living with diabetes, clinicians, researchers and patient advocates, the charter responds to a growing concern at the heart of digital health care: who owns the data produced by smart medical devices?

Continuous glucose monitors (CGMs), insulin pumps and automated insulin delivery systems generate vast amounts of highly personal health data. People with diabetes have limited access to their data or control over how that data is collected, shared and used.

Project co-leader Muireann Quigley, professor of law, medicine and technology at the University of Birmingham, said, "Across the world, people with diabetes have had their quality of life improved by smart medical devices, such as continuous glucose monitors and automated insulin pumps, to help them manage their diabetes.

"However, as with most kinds of modern technology, questions around access to and control of the data gathered by these devices and their manufacturers remain fraught.

"Users of these devices often don't have full access to their own data, or don't know how it is being used by the medical device companies.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.